# Week 1 Stakeholder Summary

## Ebola Line-list Data Quality Review

A preliminary data quality review was conducted on the Ebola line-list dataset containing 6,611 records and 28 variables.

The review identified several issues that may affect epidemiological interpretation and downstream analysis.

## Key Findings

1. Transmission-related variables had substantial missingness.
   - infection_date: 35.12% missing
   - infector: 35.14% missing
   - source: 35.14% missing

2. Outcome information was incomplete.
   - outcome: 22.69% missing
   - date_of_outcome: 16.15% missing

3. Temporal inconsistencies were detected.
   - 224 records had outcome dates before hospitalization dates.
   - This represents 3.39% of the dataset.

4. Admission time errors were detected.
   - 53 invalid admission times were found.
   - This represents 0.80% of the dataset.

5. Duplicate Records
   - Two exact duplicate records were identified and removed.
   - Final cleaned dataset contains 6,609 records.

## Public Health Implications

Missing infection dates and incomplete source/infector information may limit transmission-chain analysis and outbreak reconstruction.

Missing outcome data may affect mortality estimates and case-fatality interpretation.

Temporal inconsistencies may affect hospitalization-duration calculations and survival-type analyses.

Invalid admission times appear less widespread but should still be corrected or flagged before time-based analysis.

## Recommendations

- Review transmission-related fields with surveillance/contact-tracing teams.
- Investigate missing outcome records before estimating mortality.
- Flag records where outcome dates occur before hospitalization dates.
- Validate admission-time entry rules at the data collection stage.
- Continue monitoring duplicate record generation during data collection and ingestion.
- Preserve raw data and document all cleaning decisions.
- Use the cleaned dataset only after QC flags have been reviewed.

## Conclusion

The dataset is usable for training and exploratory analysis, but it contains important quality issues that must be documented before epidemiological reporting or modeling.